- Home
- CLEU vs NEPH Comparison
CLEU vs NEPH Comparison
Compare CLEU & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLEU
- NEPH
- Stock Information
- Founded
- CLEU 2011
- NEPH 1997
- Country
- CLEU China
- NEPH United States
- Employees
- CLEU N/A
- NEPH N/A
- Industry
- CLEU Other Consumer Services
- NEPH Medical/Dental Instruments
- Sector
- CLEU Real Estate
- NEPH Health Care
- Exchange
- CLEU Nasdaq
- NEPH Nasdaq
- Market Cap
- CLEU 20.0M
- NEPH 16.8M
- IPO Year
- CLEU 2020
- NEPH 2004
- Fundamental
- Price
- CLEU $1.93
- NEPH $2.03
- Analyst Decision
- CLEU
- NEPH Buy
- Analyst Count
- CLEU 0
- NEPH 1
- Target Price
- CLEU N/A
- NEPH $5.00
- AVG Volume (30 Days)
- CLEU 174.8K
- NEPH 12.2K
- Earning Date
- CLEU 10-11-2024
- NEPH 05-08-2025
- Dividend Yield
- CLEU N/A
- NEPH N/A
- EPS Growth
- CLEU N/A
- NEPH N/A
- EPS
- CLEU N/A
- NEPH 0.01
- Revenue
- CLEU $2,413,409.00
- NEPH $14,162,000.00
- Revenue This Year
- CLEU N/A
- NEPH $9.23
- Revenue Next Year
- CLEU N/A
- NEPH $12.99
- P/E Ratio
- CLEU N/A
- NEPH $290.01
- Revenue Growth
- CLEU N/A
- NEPH N/A
- 52 Week Low
- CLEU $0.05
- NEPH $1.36
- 52 Week High
- CLEU $7.90
- NEPH $2.55
- Technical
- Relative Strength Index (RSI)
- CLEU 50.10
- NEPH 76.08
- Support Level
- CLEU $1.80
- NEPH $1.55
- Resistance Level
- CLEU $2.24
- NEPH $1.62
- Average True Range (ATR)
- CLEU 0.30
- NEPH 0.10
- MACD
- CLEU -0.02
- NEPH 0.04
- Stochastic Oscillator
- CLEU 14.61
- NEPH 98.18
About CLEU China Liberal Education Holdings Limited
China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.